Nanjing Huawe Medicine Technology Group Co., Ltd.

Chine

Commandez votre montre hebdomadaire Nanjing Huawe Medicine Technology Group Co., Ltd.
Quantité totale PI 9
Rang # Quantité totale PI 175 819
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 242 237

Brevets

Marques

1 0
0 0
8 0
0
 
Dernier brevet 2022 - Bosutinib 1,3-propanediether dim...
Premier brevet 2017 - Indoleamine 2,3-dioxygenase inhi...

Derniers inventions, produits et services

2021 Invention Bosutinib 1,3-propanediether dimer impurity and preparation method therefor. Disclosed in the pre...
Invention Pd-l1 cyclic peptide inhibitor containing hydrazide structure. The present invention relates to a...
2020 Invention Apoptosis protein inhibitor, preparation method therefor, and use thereof. The present invention ...
Invention Anti-tumor diazobicyclic apoptosis protein inhibitor. The present invention provides a novel apop...
Invention Antitumor compound used as axl inhibitor and use thereof. Disclosed are a compound as represented...
2018 Invention Indoleamine 2,3-dioxygenase inhibitor, method for preparation and use thereof. A novel indoleamin...
Invention Indoleamine 2,3-dioxygenase inhibitor, preparation method thereof and use thereof. 12344 are as s...
2017 Invention New type indoleamine 2,3-dioxygenase inhibitor. Provided in the present invention are a new type ...
Invention Indoleamine 2,3-dioxygenase inhibitor containing hydrazino group. The present invention provides ...